Outcomes of Concomitant Bypass Surgery in Septal Myectomy
Conditions: Hypertrophic Cardiomyopathy; Coronary Artery Disease; Myocardial Bridging Interventions: Procedure: CABG during myectomy Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects
Conditions: Obstructive Hypertrophic Cardiomyopathy Interventions: Drug: HRS-1893 tablet; Drug: Verapamil tablet Sponsors: Shandong Suncadia Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Effect of Oral Intake of Bacopa Monneiri on Vascular Oxidative Stress
Conditions: Oxidative Stress; Cardiovascular Diseases; Bacopaside II; Bacopa Monnieri; Endothelial Dysfunction; Aquaporin 1; AQP1 Interventions: Dietary Supplement: Bacopa monnieri Sponsors: Cliniques universitaires Saint-Luc- Universit é Catholique de Louvain Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Conditions: Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients
Conditions: Hypotension Interventions: Other: Cardiac output monitoring by the Starling ™ SV Sebac® Sponsors: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
Conditions: Atrial Fibrillation Interventions: Other: No intervention or administration will be performed due to the observational nature of the study Sponsors: Kansas City Heart Rhythm Research Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH ）
Conditions: Cardiomyopathies Interventions: Biological: Diagnosis of HCM; Biological: Diagnosis of DCM; Biological: Diagnosis of ARVC; Biological: Diagnosis of NDLVC; Biological: Diagnosis of RCM; Biological: Diagnosis of LVNC Sponsors: First Affiliated Hospital Xi ' an Jiaotong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
Conditions: Arrhythmogenic Cardiomyopathy Interventions: Other: Diagnosis of ACM Sponsors: First Affiliated Hospital Xi ' an Jiaotong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Vitamin D3; Dietary Supplement: Prebiotics; Dietary Supplement: Vitamin D3 placebo; Dietary Supplement: Prebiotics placebo Sponsors: Huazhong University of Science and Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
WIBOFA - Validation of SCT02 With ECG-App for Detection of AF
Conditions: Atrial Fibrillation Interventions: Device: Investigational Device (Withings SCT02) 30 second Electrocardiogram recording; Device: Reference Device (Schiller Cardiovit FT-1) 30 second Electrocardiogram recording Sponsors: Withings Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
PASADENA, Calif.–(BUSINESS WIRE)–Apr. 7, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented final data from the double-blind treatment period of its Phase 2 SHASTA-2 study of investigational plozasiran (formerly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 7, 2024 Category: Pharmaceuticals Source Type: clinical trials
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
Conditions: Acute Kidney Injury; Hemolysis; Thrombocytopenia; Surgery Interventions: Other: Non-pulsatile blood flow; Other: Pulsatile blood flow Sponsors: University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure, Preserved Ejection Fraction Interventions: Drug: SGLT2 inhibitor Sponsors: Samsung Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
The ROle of Compression StocKings in Heart Failure Patients
Conditions: Heart Failure ，Congestive; Leg Edema; Venous Insufficiency; Venous Ulcers Interventions: Device: low grade compression stockings (10-15 mmHg); Device: high grade compression stockings (20-30 mmHg) Sponsors: University of Maryland, Baltimore; National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
RESTORE - Phase II
Conditions: Maternal Health Interventions: Behavioral: Low Touch - Text Messaging Implementation Strategy; Behavioral: High Touch - Community Health Worker (CHW) Implementation Strategy Sponsors: NYU Langone Health; National Heart, Lung, and Blood Institute (NHLBI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
